PLAU and lung carcinoma: NRF2 is considered a tumor suppressor, and HMOX1 its downstream effector to suppress lung cancer cells migration, via the transcriptional regulation of genes such as plasminogen activator urokinase (PLAU), MMP1, MMP9, and IGF binding protein-3 (IGFBP3).